Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > News This Week?
View:
Post by gonefishing2022 on Nov 10, 2024 7:37pm

News This Week?

Hopefully we get an update this week
Comment by menoalittle on Nov 11, 2024 9:44am
Anyone selling at this level is evidently clueless as to what this company is getting ready to do, or why they even have TLT in their portfolio... lol.  
Comment by DJDawg on Nov 11, 2024 11:25am
The ask volume is thin. If you tried to buy 20 k of shares (6,400 dollars worth let's say). You would likely spike the price to 0.34 or up 17%. That tells you that there is not much interest in selling overall. Also another reason to stay strong. A dedicated core group of TLT (science) believers holding on to their shares makes it very hard to get many shares without large impact on share ...more  
Comment by menoalittle on Nov 11, 2024 11:38am
Yeah, I doubt that 30 cents offer stays there much longer today... lol.
Comment by Legit62 on Nov 11, 2024 12:01pm
Its starting
Comment by jicoop on Nov 11, 2024 12:10pm
Not much volume...yet , so not sure if anything known. Maybe placement closed. nice to see 50K bid sitting at .30 , that is significant. Coop
Comment by menoalittle on Nov 11, 2024 12:13pm
The placement closed Friday.  
Comment by Oilminerdeluxe on Nov 11, 2024 12:14pm
Nice to see. Hope the PP closes and then Nirvana may be around the corner soon.
Comment by blackjack0 on Nov 11, 2024 12:10pm
I agree, some scattered sellers could be like myself where I had to sell a small amount in a RIFF account but I previously purchased about the same amount of shares so my position stayed the same. Sure is bullish 
Comment by blackjack0 on Nov 11, 2024 12:15pm
I forgot to mention that was the first time in over ten years that I have been invested in Theralase that I have sold a single share 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250